Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.
about
Chemotherapy for advanced non-small cell lung cancer in the elderly populationSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseSecond or third additional chemotherapy drug for non-small cell lung cancer in patients with advanced diseaseGemcitabine and Vinorelbine (GemVin) RegimenGemcitabine for the treatment of advanced nonsmall cell lung cancerHealth-related quality of life in non-small-cell lung cancer: an update of a systematic review on methodologic issues in randomized controlled trials.Triplets versus doublets, with or without cisplatin, in the first-line treatment of stage IIIB-IV non-small cell lung cancer (NSCLC) patients: a multicenter randomised factorial trial (FAST).Vinorelbine and gemcitabine vs vinorelbine and carboplatin as first-line treatment of advanced NSCLC. A phase III randomised controlled trial by the Norwegian Lung Cancer Study GroupResponse to first-line chemotherapy of docetaxel combined with platinum predicting the prognosis and subsequent treatment of patients with non-small cell lung cancerThe effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer.Development of growth inhibitory agents in urological and other malignancies.Molecular predictors of chemotherapy response in non-small-cell lung cancer.Phase II study of weekly gemcitabine and vinorelbine for children with recurrent or refractory Hodgkin's disease: a children's oncology group report.Combination chemotherapy of gemcitabine and vinorelbine for pretreated non-small-cell lung cancer: a retrospective study.Refining the treatment of advanced nonsmall cell lung cancer.Factors affecting efficacy and safety of add-on combination chemotherapy for non-small-cell lung cancer: a literature-based pooled analysis of randomized controlled trials.Effect of chemotherapy on quality of life in patients with non-small cell lung cancer.Use of the lung cancer-specific Quality of Life Questionnaire EORTC QLQ-LC13 in clinical trials: A systematic review of the literature 20 years after its development.Colony-stimulating factor use and impact on febrile neutropenia among patients with newly diagnosed breast, colorectal, or non-small cell lung cancer who were receiving chemotherapy.Elevated pretreatment serum concentration of YKL-40-An independent prognostic biomarker for poor survival in patients with metastatic nonsmall cell lung cancer.A multicenter phase II study of docetaxel, oxaliplatin, and bevacizumab in first-line therapy for unresectable locally advanced or metastatic non-squamous cell histology non-small-cell lung cancer (NSCLC).A cancer trial scandal and its regulatory backlash.[Efficacy of gemcitabine and vinorelbine in first-line treatment with advanced non-small cell lung cancer: a multicentre retrospective study].
P2860
Q24186466-C20ED0C5-C44C-4B17-B504-0024402BE477Q24200518-9ABE7F25-1C8C-452E-B3BB-813D1879E356Q24243664-42778134-B2F5-47D4-9454-493F33914C49Q33774738-1B182B07-129F-499A-88CD-D14305314E94Q33915997-AE4922DF-FDEF-4F27-A04C-76607C5DADBBQ35111780-DBDF0D3F-9E15-48B1-926E-B301401B5A3EQ35879879-A8174011-280A-4ED3-8096-FDD42783822FQ36117206-557FEA4D-0B47-40B9-B7BB-3BC446121FC1Q36439480-A9C44994-E1FB-4FA6-BCAD-1A6DD1AF15F8Q36448679-69C54616-78B6-4D92-B4FF-32627FBAB54CQ36530430-3E13468A-EE24-4487-8727-C40D5D3CEE85Q36788498-1299C3F6-ACE8-4911-AA15-BEF53A271749Q37157395-BCB65972-7207-47CD-ABB1-788EB9BC9270Q37566846-C0D3D788-1918-4EE6-9E7E-2E711DF18D77Q37645169-E1E693BC-7906-47ED-B908-E8CA331B5154Q37986608-1837727B-B3A7-439E-9939-45AB0BF0E707Q38190461-3A05CFBE-6BA4-4B91-9A02-62AD75E6E497Q38602994-DC4B851A-245B-4297-96E8-721BF91DD657Q40294108-5C45DB70-5B89-48D7-90FA-89DE0E036083Q43011817-DFD974F1-A878-48C9-8971-D484D71A1268Q43849368-F8A534AF-A3A5-457F-B281-FBB631FDDEFEQ46349887-C7929C5F-706E-4AD9-B40A-125E59D75B99Q55464467-E01BCAD4-B11E-4E84-B01A-5F41A29B8451
P2860
Randomized phase III study of gemcitabine and vinorelbine versus gemcitabine, vinorelbine, and cisplatin in the treatment of advanced non-small-cell lung cancer: from the German and Swiss Lung Cancer Study Group.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Randomized phase III study of ...... Swiss Lung Cancer Study Group.
@en
Randomized phase III study of ...... Swiss Lung Cancer Study Group.
@nl
type
label
Randomized phase III study of ...... Swiss Lung Cancer Study Group.
@en
Randomized phase III study of ...... Swiss Lung Cancer Study Group.
@nl
prefLabel
Randomized phase III study of ...... Swiss Lung Cancer Study Group.
@en
Randomized phase III study of ...... Swiss Lung Cancer Study Group.
@nl
P2093
P356
P1476
Randomized phase III study of ...... Swiss Lung Cancer Study Group.
@en
P2093
D K Hossfeld
German and Swiss Lung Cancer Study Group
I Burkholder
P304
P356
10.1200/JCO.2004.10.576
P407
P577
2004-06-01T00:00:00Z